Drug Shortage Report for ACH-PREGABALIN
| Report ID | 161316 |
| Drug Identification Number | 02449846 |
| Brand name | ACH-PREGABALIN |
| Common or Proper name | PREGABALIN |
| Company Name | ACCORD HEALTHCARE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | PREGABALIN |
| Strength(s) | 50MG |
| Dosage form(s) | CAPSULE |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | N03AX |
| ATC description | ANTIEPILEPTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-05-26 |
| Estimated end date | Unknown |
| Actual end date | 2022-08-27 |
| Shortage status | Resolved |
| Updated date | 2022-08-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-08-28 | English | Compare |
| v5 | 2022-08-27 | French | Compare |
| v4 | 2022-08-27 | English | Compare |
| v3 | 2022-05-27 | English | Compare |
| v2 | 2022-05-26 | French | Compare |
| v1 | 2022-05-26 | English | Compare |
Showing 1 to 6 of 6